These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15040523)

  • 1. Response to "Hepatitis C virus, sickle cell disease treatment options"--a February letter to the editor.
    Smoot DT
    J Natl Med Assoc; 2004 Mar; 96(3):383. PubMed ID: 15040523
    [No Abstract]   [Full Text] [Related]  

  • 2. HCV in sickle cell disease.
    Hassan M; Hasan S; Castro O; Giday S; Banks A; Smoot D
    J Natl Med Assoc; 2003 Sep; 95(9):864-7, 872-4. PubMed ID: 14527056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiviral therapy of hepatitis C].
    Erhardt A; Petry W; Ebel M; Jablonowski H; Heintges T; Häussinger D
    Z Gastroenterol; 2000 Mar; 38(3):259-69. PubMed ID: 10768250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of hepatitis C virus genotype 4.
    Abdo AA; Lee SS
    J Gastroenterol Hepatol; 2004 Nov; 19(11):1233-9. PubMed ID: 15482528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment outcome of chronic hepatitis C in sickle cell disease and thalassemic patients with interferon and ribavirin.
    Alavian SM; Tabatabaei SV
    Eur J Gastroenterol Hepatol; 2010 Jan; 22(1):123-4. PubMed ID: 19959942
    [No Abstract]   [Full Text] [Related]  

  • 6. Side effects. Safety and effectiveness of interferon and ribavirin in HIV+ people co-infected with hepatitis C virus.
    TreatmentUpdate; 2001; 12(8):4-5. PubMed ID: 12132439
    [No Abstract]   [Full Text] [Related]  

  • 7. [New drugs for hepatitis C].
    Färkkilä M
    Duodecim; 2014; 130(18):1813-22. PubMed ID: 25558623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing hepatitis C infection in HIV-positive patients.
    Craven DE; Nunes DP
    AIDS Clin Care; 2000 Sep; 12(9):71-5, 78. PubMed ID: 12170952
    [No Abstract]   [Full Text] [Related]  

  • 9. [Co-infection with HIV-hepatitis C virus].
    Bertholom C
    Rev Infirm; 2005 Oct; (114):27-8. PubMed ID: 16359042
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hepatitis C virus infection--after 20 years].
    Pár A
    Orv Hetil; 2010 Mar; 151(12):485-93. PubMed ID: 20231132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatric comorbidity does not predict interferon treatment completion rates in hepatitis C seropositive veterans.
    Dollarhide AW; Loh C; Leckband SG; Endow-Eyer R; Robinson S; Meyer JM
    J Clin Gastroenterol; 2007 Mar; 41(3):322-8. PubMed ID: 17426475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action of interferon and ribavirin in treatment of hepatitis C.
    Feld JJ; Hoofnagle JH
    Nature; 2005 Aug; 436(7053):967-72. PubMed ID: 16107837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidemiology of hepatitis C in Japan].
    Yano K; Yatsuhashi H; Yano M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):241-7. PubMed ID: 15359800
    [No Abstract]   [Full Text] [Related]  

  • 14. Focus on hepatitis. Increased RBV dose for better HCV treatment response.
    Bernard EJ
    IAPAC Mon; 2006 Jan; 12(1):18. PubMed ID: 17249131
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hepatitis C virus genotype 4: epidemiology and treatment].
    Castera L; Morice Y; Grando V; Bon C; Dény P; Roulot D
    Gastroenterol Clin Biol; 2003 Jun; 27(6-7):596-604. PubMed ID: 12910223
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined antiviral therapy for recurrent hepatitis C virus after liver transplantation.
    Fontana M; Ciuffreda D; Moradpour D; Pascual M
    Transplantation; 2007 Feb; 83(4):525-6. PubMed ID: 17318091
    [No Abstract]   [Full Text] [Related]  

  • 17. Current issues in hepatitis C, HIV co-infection discussed at lunch and learn.
    Monarch A
    Surviv News (Atlanta Ga); 2002 Sep; ():14. PubMed ID: 12765135
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of hepatitis C in Rhode Island: opportunities for improvement within and beyond the department of corrections.
    Berzin T; Allen S; Taylor L; Rich J; Feller E
    Med Health R I; 2002 Nov; 85(11):341-4. PubMed ID: 12462866
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness of interferon plus ribavirin combination in the treatment of naive patients with hepatitis C virus type 5. A French multicentre retrospective study.
    Bonny C; Fontaine H; Poynard T; Hézode C; Larrey D; Marcellin P; Bourlière M; Bronowicki JP; Merle P; Zarski JP; Sapey T; Guillemard C; Ughetto S; Henquell C; Nicolas C; Roche C; Randl K; Bommelaer G; Abergel A
    Aliment Pharmacol Ther; 2006 Aug; 24(4):593-600. PubMed ID: 16907892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advisory panel: expand hepatitis therapy to HIV/AIDS patients.
    AIDS Policy Law; 2002 Jul; 17(12):2. PubMed ID: 12134793
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.